45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
7,284
Insurances with rates
10
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 8736151_1 | INJECTION, BRENTUXIMAB VEDOTIN, 1 MG | $34,422 | $27,538 | — | — | 22 |
| 417 | LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH MCC | $33,899 | $27,120 | — | — | 11 |
| 544 | PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITHOUT CC/MCC | $32,162 | $25,730 | — | — | 11 |
| 372 | MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH CC | $31,292 | $25,033 | — | — | 11 |
| 280 | ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | $30,330 | $24,264 | — | — | 11 |
| 8557558_1 | LEAD, NEUROSTIMULATOR (IMPLANTABLE) | $27,720 | $22,176 | — | — | 22 |
| 8911026_1 | INJECTION, TILDRAKIZUMAB, 1 MG | $26,642 | $21,314 | — | — | 22 |
| 988 | NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC | $26,010 | $20,808 | — | — | 11 |
| 871 | SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC | $25,835 | $20,668 | — | — | 11 |
| 508 | MAJOR SHOULDER OR ELBOW JOINT PROCEDURES WITHOUT CC/MCC | $22,974 | $18,379 | — | — | 11 |
| 256 | UPPER LIMB AND TOE AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS WITH CC | $22,969 | $18,375 | — | — | 11 |
| 562 | FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITH MCC | $22,907 | $18,325 | — | — | 11 |
| 727 | INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC | $22,323 | $17,858 | — | — | 11 |
| 8795355_1 | INJECTION, PERTUZUMAB, 1 MG | $22,171 | $17,736 | — | — | 22 |
| 190 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC | $21,987 | $17,589 | — | — | 11 |
| 682 | RENAL FAILURE WITH MCC | $20,916 | $16,733 | — | — | 11 |
| 811 | RED BLOOD CELL DISORDERS WITH MCC | $20,656 | $16,525 | — | — | 11 |
| 872 | SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | $20,406 | $16,325 | — | — | 11 |
| 8824446_1 | INJECTION, PEMBROLIZUMAB, 1 MG | $20,185 | $16,148 | — | — | 22 |
| 8819915_1 | INJECTION, PEMBROLIZUMAB, 1 MG | $19,790 | $15,832 | — | — | 22 |
| 580 | OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH CC | $19,578 | $15,663 | — | — | 11 |
| 445 | DISORDERS OF THE BILIARY TRACT WITH CC | $19,354 | $15,483 | — | — | 11 |
| 178 | RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH CC | $19,311 | $15,449 | — | — | 11 |
| 371 | MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MCC | $19,144 | $15,315 | — | — | 11 |
| 8815756_1 | INJECTION, ATEZOLIZUMAB, 10 MG | $19,040 | $15,232 | — | — | 22 |
| 8026098_1 | LEAD, NEUROSTIMULATOR (IMPLANTABLE) | $18,684 | $14,947 | — | — | 22 |
| 312 | SYNCOPE AND COLLAPSE | $18,449 | $14,759 | — | — | 11 |
| 896 | ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC | $18,068 | $14,455 | — | — | 11 |
| 442 | DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH CC | $18,065 | $14,452 | — | — | 11 |
| 808 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS | $17,791 | $14,233 | — | — | 11 |
| 439 | DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH CC | $17,548 | $14,039 | — | — | 11 |
| 296 | CARDIAC ARREST, UNEXPLAINED WITH MCC | $17,134 | $13,707 | — | — | 11 |
| 177 | RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | $16,820 | $13,456 | — | — | 11 |
| 284 | ACUTE MYOCARDIAL INFARCTION, EXPIRED WITH CC | $16,630 | $13,304 | — | — | 11 |
| 689 | KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | $16,290 | $13,032 | — | — | 11 |
| 185 | MAJOR CHEST TRAUMA WITHOUT CC/MCC | $16,286 | $13,028 | — | — | 11 |
| 175 | PULMONARY EMBOLISM WITH MCC OR ACUTE COR PULMONALE | $16,254 | $13,004 | — | — | 11 |
| 7851110_1 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $16,205 | $12,964 | — | — | 22 |
| 091 | OTHER DISORDERS OF NERVOUS SYSTEM WITH MCC | $16,196 | $12,957 | — | — | 11 |
| 8833657_1 | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ | $15,975 | $12,780 | — | — | 22 |
| 378 | GASTROINTESTINAL HEMORRHAGE WITH CC | $15,731 | $12,585 | — | — | 11 |
| 330 | MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | $15,714 | $12,571 | — | — | 11 |
| 200 | PNEUMOTHORAX WITH CC | $15,710 | $12,568 | — | — | 11 |
| 640 | MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | $15,684 | $12,547 | — | — | 11 |
| 291 | HEART FAILURE AND SHOCK WITH MCC | $15,280 | $12,224 | — | — | 11 |
| 444 | DISORDERS OF THE BILIARY TRACT WITH MCC | $15,165 | $12,132 | — | — | 11 |
| 206 | OTHER RESPIRATORY SYSTEM DIAGNOSES WITHOUT MCC | $15,087 | $12,070 | — | — | 11 |
| 8797495_1 | INJECTION, DURVALUMAB, 10 MG | $14,930 | $11,944 | — | — | 22 |
| 8393896_1 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $14,915 | $11,932 | — | — | 22 |
| 8778894_1 | INJECTION, VEDOLIZUMAB, 1 MG | $14,653 | $11,723 | — | — | 22 |
Showing top 50 of 7,284 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.